JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
F. Henry Ellis, Jr.
Warren A. Williamson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellis, F. H.
Right arrow Articles by Balogh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellis, F. H., Jr.
Right arrow Articles by Balogh, K.

J Thorac Cardiovasc Surg 1997;113:836-848
© 1997 Mosby, Inc.

GENERAL THORACIC SURGERY

ESOPHAGOGASTRECTOMY FOR CARCINOMA OF THE ESOPHAGUS AND CARDIA: A COMPARISON OF FINDINGS AND RESULTS AFTER STANDARD RESECTION IN THREE CONSECUTIVE EIGHT-YEAR INTERVALS WITH IMPROVED STAGING CRITERIA

F. Henry Ellis, Jr., MD, PhD, Gerald J. Heatley, MS, M. J. Krasna, MD, Warren A. Williamson, MD, Karoly Balogh, MD, From the Division of Cardiothoracic Surgery and the Department of Anatomic Pathology, Deaconess Hospital, Boston, and the Departments of Thoracic and Cardiovascular Surgery and Statistics, Lahey Hitchcock Medical Center, Burlington, Mass.

Supported in part by the Jarabek Fund, Deaconess Hospital, Boston, Mass.

Received for publication July 3, 1996 accepted for publication Oct. 21, 1996. Address for reprints: F. Henry Ellis, Jr., MD, PhD, Division of Cardiothoracic Surgery, Deaconess Hospital, 110 Francis St., Boston, MA 02215.

Abstract

Objective: A review of findings and results after standard resection for carcinoma of the esophagus and cardia without neoadjuvant therapy was done to provide a basis for comparison with current reports of radical resection and neoadjuvant therapy. Methods: A 24-year experience on one surgical service with 454 operations for carcinoma of the esophagus and cardia was reviewed. A comparison of findings and results in three consecutive 8-year intervals was analyzed, and new staging criteria were developed and compared with those currently favored by the American Joint Committee on Cancer. Results: From January 1, 1970, to January 1, 1994, 454 patients with carcinoma of the esophagus or cardia underwent operation, of whom 408 (90%) had esophagogastrectomy with a 30-day mortality rate of 2.5% and an additional hospital mortality rate of 1.2%. Of the 121 complications (30.7%), 71 (18%) were major and 50 (12.7%) were minor. Cardiovascular complications predominated. The overall 5-year survival was 24.7%, with a 33.7% survival after complete resections in the most recent interval under study. Palliation of dysphagia was achieved in nearly 80% of patients who survived the operation. During the three intervals under review, resectability, mortality, and complication rates remained constant. The percentages of left thoracotomies and transhiatal resections increased, and there was a decrease in thoracoabdominal incisions. The percentages of patients with Barrett's esophagus and stage 0 and I tumors increased. The percentage of complete resections (R0) increased, whereas that for resections with residual microscopic tumor (R1) decreased, and there was no change in the percentage of patients with residual gross tumor after resection (R2). Modified WNM staging criteria are proposed that provide better prognostic stratification of the disease than those currently favored by The American Joint Committee on Cancer. Conclusions: Standard esophagogastrectomy is applicable in 90% of patients with operable carcinoma of the esophagus or cardia, with consistently low mortality and morbidity rates and satisfactory palliation of dysphagia. The 5-year survival (24.7% overall) remains suboptimal, but the current figure for complete resections (33.7%) is encouraging. There is a need for revision of the current American Joint Committee on Cancer staging criteria.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
A. C. Chang, H. Ji, N. J. Birkmeyer, M. B. Orringer, and J. D. Birkmeyer
Outcomes After Transhiatal and Transthoracic Esophagectomy for Cancer
Ann. Thorac. Surg., February 1, 2008; 85(2): 424 - 429.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. Hofstetter, A. M. Correa, N. Bekele, J. A. Ajani, A. Phan, R. R. Komaki, Z. Liao, D. Maru, T. T. Wu, R. J. Mehran, et al.
Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System
Ann. Thorac. Surg., August 1, 2007; 84(2): 365 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
Y.-G. Goan, H.-C. Chang, H.-K. Hsu, and Y.-P. Chou
An audit of surgical outcomes of esophageal squamous cell carcinoma
Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 536 - 544.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
T. J. Kim, K. H. Lee, Y. H. Kim, S. W. Sung, S. Jheon, S.-k. Cho, and K. W. Lee
Postoperative Imaging of Esophageal Cancer: What Chest Radiologists Need to Know
RadioGraphics, March 1, 2007; 27(2): 409 - 429.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
N. Rizk, E. Venkatraman, B. Park, R. Flores, M. S. Bains, and V. Rusch
The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer staging system
J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1374 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. M. Lagarde, F. J.W. ten Kate, J. B. Reitsma, O. R.C. Busch, and J. J. B. van Lanschot
Prognostic Factors in Adenocarcinoma of the Esophagus or Gastroesophageal Junction
J. Clin. Oncol., September 10, 2006; 24(26): 4347 - 4355.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. Y. Choi, K.-T. Jang, Y. M. Shim, K. Kim, G. Ahn, K.-H. Lee, Y. Choi, Y. S. Choe, and B.-T. Kim
Prognostic Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Esophageal Squamous Cell Carcinoma: Comparison With Positron Emission Tomography
Ann. Surg. Oncol., August 1, 2006; 13(8): 1054 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
L. E. Ferri, S. Law, K.-H. Wong, K.-F. Kwok, and J. Wong
The Influence of Technical Complications on Postoperative Outcome and Survival After Esophagectomy
Ann. Surg. Oncol., April 1, 2006; 13(4): 557 - 564.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. R. DeMeester
Adenocarcinoma of the Esophagus and Cardia: A Review of the Disease and Its Treatment
Ann. Surg. Oncol., January 1, 2006; 13(1): 12 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. de Manzoni, C. Pedrazzani, E. Laterza, F. Pasini, A. Grandinetti, M. Bernini, A. Ruzzenente, G. Zerman, A. Tomezzoli, and C. Cordiano
Induction Chemoradiotherapy for Squamous Cell Carcinoma of the Thoracic Esophagus: Impact of Increased Dosage on Long-Term Results
Ann. Thorac. Surg., October 1, 2005; 80(4): 1176 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
C. Alexiou, O. Khan, P. Onyeaka, L. Beggs, E. Morgan, and D. Beggs
Oesophagectomy for squamous cell carcinoma: lessons from a decade of consecutive resections
Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 180 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. R. Chirieac, S. G. Swisher, A. M. Correa, J. A. Ajani, R. R. Komaki, A. Rashid, S. R. Hamilton, and T.-T. Wu
Signet-Ring Cell or Mucinous Histology after Preoperative Chemoradiation and Survival in Patients with Esophageal or Esophagogastric Junction Adenocarcinoma
Clin. Cancer Res., March 15, 2005; 11(6): 2229 - 2236.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
N J Shaheen, J M Inadomi, B F Overholt, and P Sharma
What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis
Gut, December 1, 2004; 53(12): 1736 - 1744.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. Y. Choi, H.-J. Jang, Y. M. Shim, K. Kim, K. S. Lee, K.-H. Lee, Y. Choi, Y. S. Choe, and B.-T. Kim
18F-FDG PET in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Surgery: Prognostic Implications
J. Nucl. Med., November 1, 2004; 45(11): 1843 - 1850.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. A. Waterman, J. A. Hagen, J. H. Peters, S. R. DeMeester, C. R. Taylor, and T. R. DeMeester
The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma
Ann. Thorac. Surg., October 1, 2004; 78(4): 1161 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H.L. van Westreenen, M. Westerterp, P.M.M. Bossuyt, J. Pruim, G.W. Sloof, J.J.B. van Lanschot, H. Groen, and J.Th.M. Plukker
Systematic Review of the Staging Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer
J. Clin. Oncol., September 15, 2004; 22(18): 3805 - 3812.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
P. Koh, G. Turnbull, E. Attia, P. LeBrun, and A. G. Casson
Functional assessment of the cervical esophagus after gastric transposition and cervical esophagogastrostomy
Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 480 - 485.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. Tachibana, S. Kinugasa, H. Yoshimura, D. K. Dhar, and N. Nagasue
Extended Esophagectomy With 3-Field Lymph Node Dissection for Esophageal Cancer
Arch Surg, December 1, 2003; 138(12): 1383 - 1389.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
I. G. Kaklamanos, G. R. Walker, K. Ferry, D. Franceschi, and A. S. Livingstone
Neoadjuvant Treatment for Resectable Cancer of the Esophagus and the Gastroesophageal Junction: A Meta-Analysis of Randomized Clinical Trials
Ann. Surg. Oncol., August 1, 2003; 10(7): 754 - 761.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. G. Casson, S. C. Evans, A. Gillis, G. A. Porter, P. Veugelers, S. J. Darnton, D. L. Guernsey, and P. Hainaut
Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: Results of a ten-year prospective study
J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1121 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
J. M. Inadomi, R. Sampliner, J. Lagergren, D. Lieberman, A M. Fendrick, and N. Vakil
Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A Cost-Utility Analysis
Ann Intern Med, February 4, 2003; 138(3): 176 - 186.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. K. Dhar, M. Tachibana, N. Kinukawa, M. Riruke, H. Kohno, A. G. Little, and N. Nagasue
The Prognostic Significance of Lymph Node Size in Patients With Squamous Esophageal Cancer
Ann. Surg. Oncol., December 1, 2002; 9(10): 1010 - 1016.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A. Maier, H. Pinter, F. Tomaselli, O. Sankin, S. Gabor, B. Ratzenhofer-Komenda, and F.M. Smolle-Juttner
Retrosternal pedicled jejunum interposition: an alternative for reconstruction after total esophago-gastrectomy
Eur. J. Cardiothorac. Surg., November 1, 2002; 22(5): 661 - 665.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. W.C. Entwistle III and M. Goldberg
Multimodality therapy for resectable cancer of the thoracic esophagus
Ann. Thorac. Surg., March 1, 2002; 73(3): 1009 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. J. Swanson, H. F. Batirel, R. Bueno, M. T. Jaklitsch, J. M. Lukanich, E. Allred, S. J. Mentzer, and D. J. Sugarbaker
Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma
Ann. Thorac. Surg., December 1, 2001; 72(6): 1918 - 1925.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. A. Hagen and T. R. DeMeester
Esophageal adenocarcinoma
Ann. Thorac. Surg., October 1, 2001; 72(4): 1430 - 1432.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. B.F. Hulscher, J. G.P. Tijssen, H. Obertop, and J. J. B. van Lanschot
Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis
Ann. Thorac. Surg., July 1, 2001; 72(1): 306 - 313.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. J. Krasna, C. E. Reed, D. Nedzwiecki, D. R. Hollis, J. D. Luketich, M. M. DeCamp, R. J. Mayer, and D. J. Sugarbaker
CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer
Ann. Thorac. Surg., April 1, 2001; 71(4): 1073 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. G. Massad, P. E. Donahue, H. Rubeiz, A. G. Halline, A. Patel, T. Raghunath, N. Snow, and A. S. Geha
Paraplegia after esophagectomy: Who are the patients at risk?
J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0386 - 388.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
C.-P. Hsu, C.-Y. Chen, J.-Y. Hsia, and S.-E. Shai
Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of the thoracic esophagus
Eur. J. Cardiothorac. Surg., January 1, 2001; 19(1): 10 - 13.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. G. Casson, S. J. Darnton, S. Subramanian, and L. Hiller
What is the optimal distal resection margin for esophageal carcinoma?
Ann. Thorac. Surg., January 1, 2000; 69(1): 205 - 209.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. J. Nigro, S. R. DeMeester, J. A. Hagen, T. R. DeMeester, J. H. Peters, M. Kiyabu, G. M. R. Campos, S. Oberg, O. Gastal, P. F. Crookes, et al.
NODE STATUS IN TRANSMURAL ESOPHAGEAL ADENOCARCINOMA AND OUTCOME AFTER EN BLOC ESOPHAGECTOMY
J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 960 - 968.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
C. E. Reed
Surgical Management of Esophageal Carcinoma
Oncologist, April 1, 1999; 4(2): 95 - 105.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. J. Nigro, J. A. Hagen, T. R. DeMeester, S. R. DeMeester, J. H. Peters, S. Oberg, J. Theisen, M. Kiyabu, P. F. Crookes, and C. G. Bremner
PREVALENCE AND LOCATION OF NODAL METASTASES IN DISTAL ESOPHAGEAL ADENOCARCINOMA CONFINED TO THE WALL: IMPLICATIONS FOR THERAPY
J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 16 - 25.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. Tachibana, S. Kinugasa, D. K. Dhar, H. Tabara, R. Masunaga, T. Kotoh, H. Kubota, and N. Nagasue
Prognostic Factors in T1 and T2 Squamous Cell Carcinoma of the Thoracic Esophagus
Arch Surg, January 1, 1999; 134(1): 50 - 54.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The American Association for Thoracic Surgery.